145 related articles for article (PubMed ID: 35068754)
21. The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome.
Stella M; Locatelli L; Sala FM; Reggiani F; Calatroni M; L'Imperio V; Pagni F; Maggiore U; Moroni G; Sinico RA
Clin Kidney J; 2024 Jul; 17(7):sfae125. PubMed ID: 38962252
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological characteristics in Chinese patients with pauci-immune crescentic glomerulonephritis].
Tang Z; Yao X; Hu W
Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):740-3. PubMed ID: 10451945
[TBL] [Abstract][Full Text] [Related]
23. Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody-associated glomerulonephritis.
Nohr E; Girard L; James M; Benediktsson H
Hum Pathol; 2014 Jul; 45(7):1423-9. PubMed ID: 24784920
[TBL] [Abstract][Full Text] [Related]
24. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
[TBL] [Abstract][Full Text] [Related]
25. The role of mammalian target of rapamycin pathway in the pathogenesis of pauci-immune glomerulonephritis.
Soypacaci Z; Cakmak O; Cakalagoglu F; Gercik O; Ertekin I; Uzum A; Ersoy R; Akar S
Ren Fail; 2019 Nov; 41(1):907-913. PubMed ID: 31658846
[No Abstract] [Full Text] [Related]
26. Antineutrophil Cytoplasmic Antibodies-Negative Pauci-Immune Crescentic Glomerulonephritis Associated with Multiple Myeloma.
Anaele CU; Srisung W; Tomacruz Y; Laski M
Case Rep Nephrol Dial; 2015; 5(2):124-9. PubMed ID: 26120578
[TBL] [Abstract][Full Text] [Related]
27. Histopathological classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a nationwide Japanese prospective 2-year follow-up cohort study.
Yamagata K; Usui J; Nagata M; Sugiyama H; Sada KE; Muso E; Harigai M; Amano K; Atsumi T; Fujimoto S; Yuzawa Y; Kobayashi M; Saito T; Ito T; Hirawa N; Homma S; Dobashi H; Tsuboi N; Ishizu A; Arimura Y; Makino H; Matsuo S;
Clin Exp Nephrol; 2019 Mar; 23(3):387-394. PubMed ID: 30306344
[TBL] [Abstract][Full Text] [Related]
28. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
[TBL] [Abstract][Full Text] [Related]
29. Long-term renal outcome in pediatric glomerulonephritis associated with crescent formation.
Rianthavorn P; Chacranon M
Clin Exp Nephrol; 2018 Jun; 22(3):661-667. PubMed ID: 29101552
[TBL] [Abstract][Full Text] [Related]
30. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.
Minz RW; Chhabra S; Joshi K; Rani L; Sharma N; Sakhuja V; Duggal R; Pasricha N
Indian J Pathol Microbiol; 2012; 55(1):28-32. PubMed ID: 22499296
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.
Kapitsinou PP; Ioannidis JP; Boletis JN; Sotsiou F; Nakopoulou L; Daphnis E; Moutsopoulos HM
Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219
[TBL] [Abstract][Full Text] [Related]
32. Etiological Spectrum and Clinical Features in 215 Patients of Crescentic Glomerulonephritis: Is it Different in India?
Gupta A; Agrawal V; Kaul A; Verma R; Jain M; Prasad N; Pandey R
Indian J Nephrol; 2021; 31(2):157-162. PubMed ID: 34267438
[TBL] [Abstract][Full Text] [Related]
33. A potential pathogenic role of interleukin-6 in a child with ANCA-negative pauci-immune crescentic glomerulonephritis: case report and literature review.
Hou L; Yin L; Wu Y; Zhao C; Du Y
BMC Nephrol; 2021 Aug; 22(1):285. PubMed ID: 34425760
[TBL] [Abstract][Full Text] [Related]
34. The clinical and pathological characteristics of Chinese patients with pauci-immune crescent glomerulonephritis.
Tang Z; Yao X; Hu W; Zeng C; Chen H; Liu Z; Li L
Chin Med J (Engl); 2001 Apr; 114(4):374-8. PubMed ID: 11780457
[TBL] [Abstract][Full Text] [Related]
35. Pauci-immune crescentic glomerulonephritis.
Gupta RK
Indian J Pathol Microbiol; 2003 Jul; 46(3):357-66. PubMed ID: 15025274
[TBL] [Abstract][Full Text] [Related]
36. An Unusual Presentation of Pauci-Immune Necrotizing Glomerulonephritis.
Talon A; Tazi N
Cureus; 2020 Dec; 12(12):e12155. PubMed ID: 33489567
[TBL] [Abstract][Full Text] [Related]
37. Validation of the renal risk score for antineutrophil cytoplasmic antibody-associated glomerulonephritis in a Chinese population.
Bai X; Guo Q; Lou Y; Nie P; Zhu Y; Li B; Luo P
Clin Rheumatol; 2021 Dec; 40(12):5009-5017. PubMed ID: 34282511
[TBL] [Abstract][Full Text] [Related]
38. Predictors of renal outcomes in anti-neutrophil cytoplasmic antibody glomerulonephritis.
Jebali H; Khadhar M; Mami I; Beji S; Sellami M; Hassen M; Hmida FB; Chermiti M; Ghabi H; Salem TB; Houman H; Raies L; Zouaghi MK
Saudi J Kidney Dis Transpl; 2020; 31(1):182-190. PubMed ID: 32129212
[TBL] [Abstract][Full Text] [Related]
39. Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study.
Bjørneklett R; Bostad L; Fismen AS
Biomed Res Int; 2018; 2018():7581567. PubMed ID: 29955611
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological Characteristics and Outcomes of Diffuse Crescentic Glomerulonephritis - A Single Center Experience from Southern India.
Nagaraju SP; Laxminarayana SLK; Kosuru S; Parthasarathy R; Attur RP; Rangaswamy D; Matteti UV; Guddattu V
J Clin Diagn Res; 2017 Sep; 11(9):OC21-OC24. PubMed ID: 29207754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
